Mefloquine News and Research

RSS
Anti-malarial drug shows promise in the battle against COVID-19

Anti-malarial drug shows promise in the battle against COVID-19

Study reviews natural drug candidates for potential treatment of COVID-19

Study reviews natural drug candidates for potential treatment of COVID-19

Study identifies a host of agents with anti-SARS-CoV-2 potential

Study identifies a host of agents with anti-SARS-CoV-2 potential

Mefloquine shows potential as anti-SARS-CoV-2 drug

Mefloquine shows potential as anti-SARS-CoV-2 drug

Antimalarials could disrupt SARS-CoV-2’s Nsp1 translation termination

Antimalarials could disrupt SARS-CoV-2’s Nsp1 translation termination

Triple therapies effective and safe in malaria

Triple therapies effective and safe in malaria

Molecular-level understanding of drug interactions could pave way for better malaria treatments

Molecular-level understanding of drug interactions could pave way for better malaria treatments

Artemisinins are still strongest weapon against malaria, say experts

Artemisinins are still strongest weapon against malaria, say experts

Cochrane review provides clarity about safety of mefloquine for preventing malaria in travelers

Cochrane review provides clarity about safety of mefloquine for preventing malaria in travelers

“Super malaria” resistant to standard medications in South East Asia

“Super malaria” resistant to standard medications in South East Asia

Research shows new method for rapidly producing antimalarial drug at industrial scale

Research shows new method for rapidly producing antimalarial drug at industrial scale

TB germs' metabolic 'escape pathways' may be neutralized by new drugs to shorten duration of therapy

TB germs' metabolic 'escape pathways' may be neutralized by new drugs to shorten duration of therapy

Researchers suggest possible novel target for seizure-blocking medicines

Researchers suggest possible novel target for seizure-blocking medicines

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

Viewpoints: Fears of health law's adverse selection; GOP's 'fundamental miscalculation;' special deal for Congress keeps dissent low

Viewpoints: Fears of health law's adverse selection; GOP's 'fundamental miscalculation;' special deal for Congress keeps dissent low

WHO includes new paediatric therapeutic options to EMLc

WHO includes new paediatric therapeutic options to EMLc

Fewer malaria cases, more artesunate resistance on Thai border

Fewer malaria cases, more artesunate resistance on Thai border

DNDi in Latin America wins Carlos Slim Health Award for innovations in drug development

DNDi in Latin America wins Carlos Slim Health Award for innovations in drug development

Scientists report on development of new malaria drug

Scientists report on development of new malaria drug

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition